
The FDA approved Paxlovid as the first oral drug to treat COVID-19
FDA has approved the use of the oral tablet Paxlovid for the treatment of mild-to-moderate COVID-19 in adults and children over 12 years of age

COVID-19 Data Portal Poland has become part of ELIXIR-CONVERGE
As of December 2021, the development of infrastructure and service offered by the Institute of Bioorganic Chemistry PAS together with the affiliated Poznan Supercomputing and Networking Center via COVID-19 Data Portal Poland (COVID-HUB)

Omicron likely to weaken COVID vaccine protection, but boosters should improve immunity
Initial laboratory studies by Pfizer-BioNTech showed that three doses of BNT162b2 vaccine increased the titer of neutralizing antibodies against the new variant SARS-CoV-2 Omicron (B.1.1.529)

SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
A study published in Cell using transcriptomic, radiological and histopathological data showed that SARS-CoV-2 infection induced an influx of profibrotic macrophages (CD163) into the lung.

Digital transformation of droplet/aerosol infection risk assessment realized on “Fugaku” for the fight against COVID-19
Japanese scientists developed an innovative SARS-CoV-2 aerosol transmission model based on next-generation large-scale and multi-physics simulations.

Intelligent Resolution: Integrating Cryo-EM with AI-driven Multi-resolution Simulations to Observe the SARS-CoV-2 Replication-Transcription Machinery in Action
The research using modern Cryo-EM microscopy in combination with artificial intelligence explains the molecular processes of SARS-CoV-2 replication inside the host cell.